Concourse Financial Group Securities, Inc. Enanta Pharmaceuticals Inc Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENTA
# of Institutions
109Shares Held
21.2MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$10.8 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$10.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$9.44 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$7.66 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.1MShares$5.64 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $106M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...